| The expression and prognostic value of miR-146a and miR-155 in Turkish patients with multiple sclerosis F Saridas, H Tezcan Unlu, G Cecener, U Egeli, M Sabour Takanlou, ... Neurological Research 44 (3), 217-223, 2022 | 9 | 2022 |
| Multiple skleroz gelişimi ile ilişkili miRNA'ların araştırılması F Sarıdaş PQDT-Global, 2018 | 5 | 2018 |
| İnme Etiyolojisinde Obstrüktif Uyku Apne Sendromunun Yeri F Sarıdaş, AB Demir, M Zarifoğlu, İ Bora Journal of Turkish Sleep Medicine 3, 69-71, 2015 | 4 | 2015 |
| Investigation of miR-146a expression profiles in fecal samples of patients with multiple sclerosis for early diagnosis and treatment HT Unlu, F Saridas, O Taskapilioglu, G Cecener, U Egeli, OF Turan, ... Neurological Sciences and Neurophysiology 40 (2), 81-87, 2023 | 2 | 2023 |
| Real-world experience of ocrelizumab in MS in the Turkish population: A singlecenter study E Koc, F Saridas, D Ceylan, O Turan, G Ozkaya European Journal of Neurology, 792-792, 2022 | 1 | 2022 |
| The role of obstructive sleep apnea syndrome as a cause of stroke F Saridas, A Demir, M ZARİFOĞLU, I Bora JOURNAL OF TURKISH SLEEP MEDICINE-TURK UYKU TBB DERGISI 2 (3), 2015 | 1 | 2015 |
| Lateralizing value and clinicoradiological features of asymmetric last clonic jerks in temporal and extratemporal epilepsy F Saridas, G Mesut, Y Dinc, A Bican Demir, I Bora Scientific Reports 14 (1), 11578, 2024 | | 2024 |
| Fokal Başlangıçlı Bilateral Tonik Klonik Nöbetlerde Nöbet Süresi ile Demografik, Klinik ve Radyolojik Özellikler Arasındaki İlişkinin Araştırılması F Sarıdaş, G Mesut, AB Demir, İ Bora Uludağ Üniversitesi Tıp Fakültesi Dergisi 50 (1), 53-60, 2024 | | 2024 |
| Multipl Skleroz Hastalarında Hastalık Modifiye Edici Tedavilere Uyumu Etkileyen Faktörlerin Değerlendirilmesi ER Koç, F Sarıdaş, ÖF Turan Uludağ Üniversitesi Tıp Fakültesi Dergisi 50 (1), 1-4, 2024 | | 2024 |
| Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology F Saridas, G Mesut, CY Ceylan, R Ozpar, M Ozsen, ER Koc, S Tolunay, ... Multiple Sclerosis and Related Disorders 85, 105537, 2024 | | 2024 |
| Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-remitting multiple sclerosis at baseline and first-year follow-up F Saridas, FM Saridas, ER Koc, OF Turan Heliyon 10 (5), 2024 | | 2024 |
| Characteristics of Cerebral Venous Sinus Thrombosis Due to Autoimmune Diseases: A Single-Center Retrospective Observational Study F Saridas, G Mesut, Y Dinc, ER Koc, R Ozpar, B Hakyemez, OF Turan The Neurologist, 10.1097, 2024 | | 2024 |
| Fingolimod real life experience in non-naive multiple sclerosis patients F Sarıdaş, ER Koç, G Özkaya, ÖF Turan The European Research Journal, 1-9, 2024 | | 2024 |
| D Vitamininin Fingolimod Tedavisi Alan Multipl Skleroz Hastaları Üzerine Etkisinin Araştırılması F Sarıdaş, SH Lazrak, ER Koç, ÖF Turan Uludağ Üniversitesi Tıp Fakültesi Dergisi 49 (3), 297-303, 2023 | | 2023 |
| How much are we understandable? The Effect of Health Literacy on Disease Perception and Treatment Compliance in Multiple Sclerosis Patients E Koc, F Saridas, S Minaz, OF Turan, G Ozkaya, H Demirci MULTIPLE SCLEROSIS JOURNAL 29, 197-197, 2023 | | 2023 |
| Cladribine responsiveness in switched rrms patients N Tepe, E Koc, F Saridas, F Akkoyun, US Sari, OF Turan, SC Kabay, ... | | 2023 |
| Efficacy of Accelerated Vaccination against Hbv to Achieve Antibody formation in Multiple Sclerosis Patients Receiving Anti-Cd20 Therapy ER Koc, OF Turan, F Saridas, B Menguc, SN Minaz, G Ozkaya Annals of Indian Academy of Neurology 26 (5), 697-701, 2023 | | 2023 |
| Sectoral and Quadrant Evaluation of the Peripapillary Retinal Nerve Fiber Layer and Ganglion Cell–inner Plexiform Layer Thickness in Patients with Multiple Sclerosis ER Koç, ES Sarı, F Sarıdaş, ÖF Turan Turkish Journal of Neurology 29 (4), 282-286, 2023 | | 2023 |
| Etiology, Clinical Characteristics and In-hospital Mortality of Status Epilepticus: Single Center Experience F Sarıdaş, A DEMİR Archives of epilepsy (Online) 29 (1), 2023 | | 2023 |
| CLINICAL EXPERIENCES IN PSYCHOGENETIC NONEPILEPTIC SEIZURES BETWEEN 2003 AND 2016 XPLAINING THE DIAGNOSIS IS THE FIRST AND MOST IMPORTANT STEP OF THE TREATMENT IN CLINICAL … BA Demir, I Bora, F Saridas EPILEPSIA 57, 197-197, 2016 | | 2016 |
